Alzheimer’s blood test, Aducanumab approval issues, Medicare coverage of brain scans that diagnose dementia, Some at higher risk for Alzheimer’s
Defying convention
By
John Hall
Feb 01, 2017
Conventional wisdom holds that tech innovations are slow to take hold in senior living. Conventional wisdom is wrong.
Brookdale ‘whistleblower’ suit dismissed
By
John Hall
Apr 06, 2015
A federal judge has dismissed a former Brookdale Senior Living employee’s False Claims Act suit against the company while leaving the door open for an amended complaint, according to published reports
A Q&A with NIC’s Robert Kramer
By
John Hall
Sep 13, 2016
Robert G. Kramer, founder and CEO of the National Investment Center for Seniors Housing & Care, recently spoke with McKnight’s about the current state and future prospects of independent living,...
Congress gets tough on EHR interoperability
By
John Hall
Mar 23, 2015
Providers using incompatible or uncertified electronic health record systems by the end of 2018 could face reduced Medicare reimbursements under a bill introduced Thursday in both houses of Congress.
Focus on briefs: Medication management
Apr 12, 2024
PharMerica selects SinguLab to deliver pharmacogenomics solutions, Drug shortages shrouded in mystery
A positive early verdict for AI in LTC, with caveats noted
By
John Hall
Jun 21, 2024
Experts say artificial intelligence tools have the potential to free staff for critical tasks and to offer deeper insights into community operations.
More seniors may be willing to take deprescribing advice
By
John Hall
Apr 12, 2024
Providers, however, must continue to check their motivation in cutting back on certain prescriptions, pharmacy experts caution.
Health experts weigh in with opinions on coming flu season
By
John Hall
Dec 03, 2023
Experts advise providers to stay ahead of potential disease outbreaks by working collaboratively with pharmacies on vaccination campaigns.
Assisted living residents with dementia receiving too many antipsychotics, GAO says
By
John Hall
Mar 03, 2015
Government investigators are calling for greater scrutiny of antipsychotics use among residents with dementia in settings beyond nursing homes.